Published on

CDSCO Manufacturing License for Cardiopulmonary bypass defoamer

Authors
  • avatar
    Name
    CDSCO Licenses Blog
    Twitter

Introduction

The Central Drugs Standard Control Organization (CDSCO) has a pivotal role in the Indian healthcare sector. It's the national authority for regulating medical devices, ensuring quality standards and safety are met. A major part of its duties involves issuing manufacturing licenses for different grades of medical devices. This not only maintains the standard of medical appliances, but also safeguards the health of patients using such devices.

Given this context, we'll be talking about the Cardiopulmonary bypass defoamer, a class C medical device. The CDSCO classifies this device as having moderate to high risk, hence subject to stringent oversight and regulation.

The Cardiopulmonary bypass defoamer plays a critical role in cardiothoracic surgeries, we'll delve into this further as we proceed. Visit CDSCO's portal for more information on the same.

What is a Cardiopulmonary Bypass Defoamer?

A Cardiopulmonary bypass defoamer is a device used within the medical sphere to eliminate gas bubbles from the blood during cardiopulmonary bypass surgery. The device works hand in hand with an oxygenator, ensuring a seamless surgical process.

Owing to its medical significance, the device is commonly used during complex procedures involving the heart and lungs, often related to open-heart surgeries and heart transplantation. It works to maintain the condition of the blood, ensuring it remains functional and safe for the patient.

The Role of CDSCO in Medical Device Regulation

Having been established with a mission to safeguard the health of millions, CDSCO is responsible for enforcing standards and quality in the production and distribution of medical devices. It oversees the guideline development, compliance monitoring, and license issuance for the manufacture of medical devices, such as the Cardiopulmonary bypass defoamer.

The regulatory framework encompasses risk-based categorization of the devices and relevant license issuance. For class C devices like the Cardiopulmonary bypass defoamer, the MD9 license applies, which is more stringent with its adherence to norms than for lower risk class.

How to manufacture a Cardiopulmonary bypass defoamer

Manufacturing a Cardiopulmonary bypass defoamer is an intricate process requiring significant technical knowledge and adhering to stringent guidelines by CDSCO to ensure the device is of superior quality and fit for its intended use. Processes involved range from gas bubble detection to elimination, within a framework of continual quality control assessments.

Fees for manufacturing license for a Cardiopulmonary Bypass Defoamer

For the manufacture of a Cardiopulmonary bypass defoamer, which falls under the risk class C, an MD9 license is required. The cost of obtaining an MD9 license amounts to Rs. 50,000 with an additional fee of Rs. 1000 per product for the Cardiopulmonary bypass defoamer.

Why is a Manufacturing License Necessary for Cardiopulmonary Bypass Defoamer?

Obtaining a manufacturing license is not only mandatory, it's crucial to maintain quality standards in medical device production. It ensures compliance with designated healthcare regulations, providing a shield to consumers and patients from sub-par, potentially harmful products. Given its life-saving purpose, a Cardiopulmonary bypass defoamer must meet high quality and safety standards, and a license is evidence of this.

Steps to Obtain a CDSCO Manufacturing License for Cardiopulmonary Bypass Defoamer

The procedure to obtain a license for Cardiopulmonary bypass defoamer involves the submission of necessary documents, such as the Device Master File, Quality Management Certificate, Device Details, Site details, etc. The process can be classified into:

  1. Submission of documents
  2. Assessment by CDSCO
  3. Addressal of any issues raised
  4. License approval

While the process can be challenging, staying informed about the regulations and preparation can ease the process.

Frequently Asked Questions (FAQs)

Q1. What is the risk class of Cardiopulmonary Bypass Defoamer as per Medical Device Rules, 2017?

It falls under risk class C.

Q2. What license is needed to manufacture Cardiopulmonary Bypass Defoamer?

To manufacture Cardiopulmonary Bypass Defoamer, you'll need an MD9 license.

Q3. What is the fee for an MD9 license for a Cardiopulmonary Bypass Defoamer?

The fee for an MD9 license for a Cardiopulmonary Bypass Defoamer is Rs. 50,000, with an additional fee of Rs. 1,000 per product.

Q4. Who will issue the manufacturing license for a Cardiopulmonary Bypass Defoamer?

For the class C Cardiopulmonary Bypass Defoamer, the CDSCO HQ in New Delhi will issue the license.

Q5. Is repackaging of a Cardiopulmonary Bypass Defoamer considered manufacturing?

Yes, the repackaging of Cardiopulmonary Bypass Defoamer is considered manufacturing. As per the Drugs and Cosmetics Act, repackaging is considered manufacturing and requires a license. In this case, you'd need an MD9 license.

Conclusion

The process of obtaining a license to manufacture medical devices can be daunting. However, with the right guidance and support, you can navigate the process effectively. Feel free to reach out to Pharmadocx Consultants for expert assistance with the licensing process. You can also contact us directly by calling +91-7404557227 or emailing [email protected]. For more detailed information on MD9 license, refer to this article.

cdsco import license in india banner
cdsco manufacturing license in india banner